AyurMaya Capital Management Company, LP - 21 May 2025 Form 4 Insider Report for ACELYRIN, Inc. (SLRN)

Signature
AyurMaya Capital Management Company, LP, By AyurMaya Capital Management Company GP, LLC, Its General Partner, By: /s/ David E. Goel, Managing Member
Issuer symbol
SLRN
Transactions as of
21 May 2025
Net transactions value
$0
Form type
4
Filing time
23 May 2025, 16:23:20 UTC
Previous filing
03 Jul 2024

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
AyurMaya Capital Management Company, LP Director, Other*, 10%+ Owner 3 PLEASANT STREET, SUITE 400, PORTSMOUTH AyurMaya Capital Management Company, LP, By AyurMaya Capital Management Company GP, LLC, Its General Partner, By: /s/ David E. Goel, Managing Member 23 May 2025 0001975990
GOEL DAVID E. Director, Other*, 10%+ Owner 3 PLEASANT STREET, SUITE 400, PORTSMOUTH /s/ David E. Goel 23 May 2025 0001548144

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRN Common Stock, par value $0.00001 per share ("Common Stock") Disposed to Issuer $0 -9,334,735 -100% $0.000000 0 21 May 2025 See footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

AyurMaya Capital Management Company, LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Agreement and Plan of Merger, as amended on April 20, 2025, by and among Alumis Inc., a Delaware corporation ("Alumis") and ACELYRIN, Inc., a Delaware corporation (the "Issuer") and the other parties thereto, each share of Common Stock was cancelled and converted into the right to receive 0.4274 shares of Common Stock, without interest and, if applicable, cash in lieu of fractional shares, subject to any applicable withholding.
F2 The securities reported herein were held by AyurMaya Capital Management Fund, LP (the "AyurMaya Fund"). AyurMaya Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager.
F3 The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.

Remarks:

The Investment Manager may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Mr. Alan Colowick, Senior Managing Director of Matrix Capital Management Company LP, an affiliate of the Investment Manager, currently serves on the board of directors of the Issuer.